Allergy & Immunology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
Conditions: Epidermolysis Bullosa Dystrophica Interventions: Other: Sampling Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials

Antibody Reduces Allergic Reactions to Multiple Foods in NIH Trial
December 19, 2023 -- A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without an allergic reaction, according to a planned interim analysis of an... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 19, 2023 Category: Pharmaceuticals Source Type: clinical trials

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
Conditions: Gram-negative Bacteremia; Bloodstream Infection Interventions: Diagnostic Test: Reveal Sponsors: Duke University; National Institute of Allergy and Infectious Diseases (NIAID); Parexel; BioM érieux Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis
Conditions: Allergic Rhinitis Interventions: Behavioral: Ordinary moxibustion volume group; Behavioral: First group of heavy moxibustion; Behavioral: Second groups of heavy moxibustion Sponsors: Henan University of Traditional Chinese Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Conditions: Allergic Bronchopulmonary Aspergillosis Interventions: Drug: Prednisolone; Drug: Itraconazole Sponsors: Postgraduate Institute of Medical Education and Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

Pre-hospital pulse glucocorticoid therapy in patients with ST-segment elevation myocardial infarction transferred for primary percutaneous coronary intervention: a randomized controlled trial (PULSE-MI)
DiscussionWe hypothesize that pulse-dose methylprednisolone administrated in the pre-hospital setting decreases inflammation and thus reduces final infarct size in patients with STEMI treated with primary PCI.Trial registrationEU-CT number: 2022 –500762-10–00; Submitted May 5, 2022. ClinicalTrials.gov Identifier: NCT05462730; Submitted July 7, 2022, first posted July 18, 2022. (Source: Trials)
Source: Trials - December 15, 2023 Category: Research Source Type: clinical trials

NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates
December 14, 2023 -- An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 14, 2023 Category: Pharmaceuticals Source Type: clinical trials

Study of CM310 in Subjects With Seasonal Allergic Rhinitis
Conditions: Seasonal Allergic Rhinitis Interventions: Biological: CM310 Sponsors: Keymed Biosciences Co.Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials

Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Conditions: Nervous System Disease; Immune System Disease Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials

Immunerecov contributes to improvement of respiratory and immunological response in post-covid-19 patients.
Conditions: Long Covid19; Dietary Supplements; Respiratory Tract Infections; Inflammation Interventions: Dietary Supplement: Nutritional blend (ImmuneRecov). Sponsors: Federal University of S ão Paulo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

Allergy Diagnostic Test Based on Microchip Technology
Conditions: Allergy; Allergy;Food; Allergy Pollen; Allergy Drug Interventions: Diagnostic Test: Routine allergy tests; Diagnostic Test: Newly developed microarray-based diagnostic test system Sponsors: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
Conditions: Flu; Cold Interventions: Dietary Supplement: Feihe Investigational Formula; Dietary Supplement: Control Formula; Other: Breastfeeding Sponsors: Heilongjiang Feihe Dairy Co. Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED
Conditions: COVID-19 Interventions: Behavioral: Vaccine Messaging; Behavioral: Vaccine Acceptance Question Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer; Duke University; Baylor College of Medicine; Thomas Jefferson University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

A Study of TL-925 for the Treatment of Allergic Conjunctivitis
Conditions: Allergic Conjunctivitis Interventions: Drug: TL-925; Drug: Placebo Sponsors: Telios Pharma, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials

Investigation of Immune Amnesia Following Measles Infection in Select African Regions
Conditions: Measles Infection Interventions: Biological: Verorab Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Johns Hopkins University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2023 Category: Research Source Type: clinical trials